Showing results (11-20 of 68) with videos related to
Sort By:
Pageof 7
Leukemia & Lymphoma|March 10, 2015
Treatment of patients with secondary central nervous system lymphoma with high-dose busulfan/thiotepa-based conditioning and autologous stem cell transplantDanielle H Oh, Neil Chua, Lesley Street, et al.Leukemia & Lymphoma|March 5, 2003
Successful treatment of posttransplant lymphoproliferative disorder in a renal transplant patient by autologous peripheral blood stem cell transplantationNicola A M Bobey, Douglas A Stewart, Richard C WoodmanLeukemia & Lymphoma|October 26, 2011
Upfront thiotepa, busulfan, cyclophosphamide, and autologous stem cell transplantation for primary CNS lymphoma: a single centre experienceNimira Alimohamed, Andrew Daly, Carolyn Owen, et al.Journal of Surgical Oncology|April 7, 2009
The role of surgical intervention in the management of duodenal lymphomaKourosh Sarkhosh, Oliver F Bathe, Douglas A Stewart, et al.Leukemia & Lymphoma|September 21, 2011
Double high-dose therapy with dose-intensive cyclophosphamide, etoposide, cisplatin (DICEP) followed by high-dose melphalan and autologous stem cell transplantation for relapsed/refractory Hodgkin lymphomaMona Shafey, Qiuli Duan, James Russell, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 10, 2019
Outcomes of Consecutively Diagnosed Primary Central Nervous System Lymphoma Patients Using the Alberta Lymphoma Clinical Practice Guideline Incorporating Thiotepa-Busulfan Conditioning for Transplantation-Eligible PatientsSheilagh Sanders, Neil Chua, Jean-François Larouche, et al.CMAJ Open|December 1, 2021
Physician perspectives on delays in cancer diagnosis in Alberta: a qualitative studyAnna Pujadas Botey, Kathy GermAnn, Paula J Robson, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 31, 2017
Incidence of late onset neutropenia associated with rituximab use in B cell lymphoma patients undergoing autologous stem cell transplantationVincent H Ha, Sunita Ghosh, Catherine Leyshon, et al.Leukemia & Lymphoma|July 12, 2011
Durable event-free survival following autologous stem cell transplant for relapsed or refractory follicular lymphoma: positive impact of recent rituximab exposure and low-risk Follicular Lymphoma International Prognostic Index scoreAnthea C Peters, Qiuli Duan, James A Russell, et al.Leukemia & Lymphoma|May 12, 2023
Return on investment of the lymphoma diagnostic pathway implementation in Alberta, CanadaArianna Waye, Nguyen X Thanh, Tim Buckland, et al.Pageof 7